23andMe Holding Co (ME)
0.5452
-0.01
(-2.33%)
USD |
NASDAQ |
May 31, 16:00
0.5452
0.00 (0.00%)
After-Hours: 20:00
23andMe Free Cash Flow: -173.98M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -173.98M |
December 31, 2023 | -194.28M |
September 30, 2023 | -157.72M |
June 30, 2023 | -172.82M |
March 31, 2023 | -176.70M |
December 31, 2022 | -166.85M |
September 30, 2022 | -215.59M |
Date | Value |
---|---|
June 30, 2022 | -210.82M |
March 31, 2022 | -180.80M |
December 31, 2021 | -183.45M |
September 30, 2021 | -129.73M |
June 30, 2021 | -90.09M |
March 31, 2021 | -81.63M |
Free Cash Flow Range, Past 5 Years
-215.59M
Minimum
Sep 2022
-81.63M
Maximum
Mar 2021
-164.19M
Average
-173.98M
Median
Mar 2024
Free Cash Flow Benchmarks
RadNet Inc | 16.32M |
DermTech Inc | -72.07M |
iSpecimen Inc | -8.536M |
Sera Prognostics Inc | -18.11M |
Progyny Inc | 190.34M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -25.78M |
Cash from Investing (Quarterly) | -2.146M |
Cash from Financing (Quarterly) | 2.00M |
Free Cash Flow Per Share (Quarterly) | -0.0575 |
Free Cash Flow to Equity (Quarterly) | -27.95M |
Free Cash Flow to Firm (Quarterly) | -27.95M |
Free Cash Flow Yield | -67.05% |